Studies of murine lupus models and serial studies of SLE patients have shown that the IFN pathways are involved in a significant increase in the expression of IFN-regulated genes, the broad enhancement and regulation of immune cells, and autoimmune inflammation in SLE. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.